Navigation Links
MD Biosciences Announces the Release of a Diagnostic Test for Zika Virus
Date:3/1/2016

SAINT PAUL, Minn., March 1, 2016 /PRNewswire/ -- MD Biosciences, Inc. Clinical and Diagnostic Services Laboratory announces the release of its rapid assay to detect the virus in human blood and urine samples. The nucleic acid test can be performed in a few hours in blood, plasma, serum or urine samples. The test is specific for the Zika virus and was shown not to cross react with other infectious viruses such as Dengue, West Nile or Chikunguya. The laboratory-developed test is available immediately.

The World Health Organization states that the spread of the mosquito-borne virus will grow explosively throughout the Americas. According to the CDC, the virus has also been shown to be transmitted through sexual contact. Upwards of four million infections are expected in the region. Close to 80% of infections are asymptomatic while others suffer from fever, rash, joint aches and other hallmarks. A steep increase in birth defects and Guillain-Barre syndrome has correlated to the spread of the virus. The explosive spread of the virus, along with major crowd and traveller-related events such as this year's Olympic Games in Brazil, have created the need for steps in fighting the virus, including the ability to rapidly and specifically identify the infection.

Eddie Moradian, Chief Executive Officer at MD Biosciences states, "We are extremely proud of our CLIA diagnostics laboratory's ability to provide a reliable, accurate and rapid method of testing for Zika virus. This demonstrates our commitment in placing our expertise, knowledge and infrastructure for the betterment of health, in the US and throughout the world, whether through the development of more advanced diagnostics or by advancing newer, better and more efficient therapies."

About MD Biosciences, Inc.
MD Biosciences is a leading provider of clinical and preclinical services with over 25 years of experience in the clinical diagnostics and preclinical research areas. Services are provided for cancer, inflammatory, metabolic and neurological diseases. MD Biosciences laboratories provide extensive experience in working with biomarkers and developing validated laboratory assays. MD Biosciences operates through its facilities and laboratories in the United States, Switzerland and Israel.

Located in Saint Paul, MN, MD Biosciences' Clinical and Diagnostic Services Laboratory is a CLIA accredited laboratory for high complexity testing. All testing is performed under stringent guidelines in state of the art laboratories. Other services include clinically relevant tests for genetic markers of diseases including various cancers.

 

Inquiries may be directed to:
Eddie Moradian, PhD, Chief Executive Officer
Susan Belzer, Vice President, MD Biosciences Clinical Diagnostics Laboratory

by e-mail: Email
by telephone to 1-888-USMDBIO (1 888 876 3246) or (651) 641 1770.


'/>"/>
SOURCE MD Biosciences, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. ARMO BioSciences to Present at Cowen and Company 36th Annual Heath Care Conference
2. Kindred Biosciences Submits Zimeta (KIND-012) New Animal Drug Application Technical Section for Effectiveness to FDA
3. Silicon Biosystems Menarini, Swift Biosciences Announce Collaboration and Co-Marketing Partnership to Unlock Genomic Information from FFPE Samples
4. Sangamo BioSciences Reports Fourth Quarter And Full Year 2015 Financial Results
5. Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2015 Results
6. Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
7. Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference
8. ARMO BioSciences to Present at the Leerink Partners Global Healthcare Conference
9. Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
10. Kindred Biosciences Releases Positive Results of Pilot Field Study of KIND-010 for the Management of Weight in Cats
11. Dramatic Turn in Story of Invalidated 813 Patent For Treating Binge Eating Disorder as Owner Lucerne Biosciences Provides Patent Board Profile of itself and its High 40-75% Misrepresentation Rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... ... ... RxNT announced today that it has been named by Software Advice ... a leader in healthcare technology solutions. This is the fourth time RxNT has received ... best software products from North American small businesses. RxNT won the FrontRunner mental health ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... of health to improve patient outcomes, recently announced the launch of its new ... and pharmacies to develop a customized, local network of community resources focused on ...
(Date:6/13/2019)... Pa. (PRWEB) , ... June 13, 2019 , ... ... organization in the northeastern United States, today announced the appointment of Frank Ingari ... directly to Chief Executive Officer Anthony Coletta, M.D., M.B.A. , With more ...
Breaking Medicine Technology:
(Date:6/13/2019)... NEW YORK (PRWEB) , ... ... ... of 3D printing—including medical and dental implants, additive manufacturing (AM)-enabled tissue fabrication, ... Every day, physicians are using AM medical technologies to improve patient care. ...
(Date:6/12/2019)... Va. (PRWEB) , ... June 12, 2019 , ... ... Andrea Miller, a quality assurance expert with more than 25 years of experience ... MDD Compliance for all classes of medical devices, has joined NDA Partners as ...
(Date:6/12/2019)... ... June 12, 2019 , ... We are excited ... for UPMC Pinnacle, a top-rated healthcare system, providing cutting-edge fertility treatment to patients ... for many premier insurance plans because of our commitment to evidence-based medicine and ...
(Date:6/11/2019)... ... 11, 2019 , ... Homecare Homebase (HCHB), the nation’s leader ... Management (RCM) service at the company’s annual Users Conference this week in Dallas. ... Services Suite, a collection of technology-enabled services designed to alleviate the burden associated ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... the call for speaker proposals for its fourth annual Accountable Care Symposium on ... , The annual symposium brings together hundreds of health care leaders and providers ...
Breaking Medicine News(10 mins):